https://www.geuvih.org/wp-content/uploads/2019/07/RESPUESTAS.jpg300300Héctor González Suárezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgHéctor González Suárez2019-07-27 19:03:462019-07-27 20:50:26Respuestas de la Encuesta sobre VIH
https://www.geuvih.org/wp-content/uploads/2019/03/noticias.jpg5001000Marcelo Alvezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgMarcelo Alvez2019-04-26 07:27:502019-04-26 07:40:25Pharmacokinetics and Safety of the Integrase Inhibitors Elvitegravir and Dolutegravir in Pregnant Women With HIV - Annals of Pharmacotherapy 2019
https://www.geuvih.org/wp-content/uploads/2019/04/pareja.jpg7171080adminhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgadmin2019-04-09 12:36:312019-04-09 12:36:33Todo lo que querés saber sobre el VIH en las relaciones y no te animás a preguntar
https://www.geuvih.org/wp-content/uploads/2019/07/geu_1800x600.jpg6001800Marcelo Alvezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgMarcelo Alvez2019-07-26 01:25:282019-07-27 19:43:45Completa la encuesta sobre VIH
https://www.geuvih.org/wp-content/uploads/2019/07/antirretrovirales.jpg5651000Marcelo Alvezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgMarcelo Alvez2019-07-26 00:11:022019-07-27 19:44:09Tratamiento Antirretroviral y Cura del HIV
https://www.geuvih.org/wp-content/uploads/2019/07/vih-oms.png4351000Marcelo Alvezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgMarcelo Alvez2019-07-26 00:04:432019-07-27 19:44:34La OMS recomienda el Dolutegravir como tratamiento preferido de la infección por VIH
https://www.geuvih.org/wp-content/uploads/2019/07/pep.jpg5681000Marcelo Alvezhttp://www.geuvih.org/wp-content/uploads/2019/03/logo-GEUVIH-300x300.jpgMarcelo Alvez2019-07-25 23:58:042019-07-27 19:45:01PEP y PrEP en prevención combinada